ArticleCancer research2015

Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.

Hanna Taipaleenmäki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.